Cue Biopharma, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Cue Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2023.
  • Cue Biopharma, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $2.35M, a 507% increase year-over-year.
  • Cue Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $11.9M, a 77.9% decline from 2022.
  • Cue Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $53.7M, a 179% increase from 2021.
  • Cue Biopharma, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $19.2M, a 67.2% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.9M -$41.8M -77.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $53.7M +$34.4M +179% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $19.2M -$39.4M -67.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-21
2020 $58.6M +$7.82M +15.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
2019 $50.8M +$46.6M +1115% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $4.18M -$57.8M -93.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $62M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.